Skip to main content
. 2018 Jan 7;24(1):76–86. doi: 10.3748/wjg.v24.i1.76

Table 6.

Univariate and multivariate analyses of 211 pathological T4 colorectal cancer patients for disease-free survival

Univariate analysis
Multivariate analysis
Variable HR (95%CI) P value HR (95%CI) P value
Age 1.621 (1.010-2.601) 0.045 1.892 (1.111-3.223) 0.419
Gender 1.328 (0.824-2.141) 0.243
Surgical method (LAP and OPEN) 1.503 (0.933-2.422) 0.094
Tumor location
Mid/upper rectum Reference group -
Left colon 1.010 (0.601-10697) 0.969
Right colon 0.818 (0.411-1.629) 0.568
Comorbidities 1.787 (1.058-3.019) 0.030 2.261 (1.235-4.139) 0.080
pT4a/b 0.818 (0.618-1.725) 0.013 1.214 (0.784-1.974) 0.001
N stage
N0 Reference group -
N1 1.134 (0.594-2.167) 0.703
N2 1.553 (0.861-2.801) 0.144
TNM stage
IIB + IIC Reference group - Reference group -
IIIB 1.034 (0.471-2.269) 0.933 0.884 (0.393-1.989) 0.765
IIIC 2.284 (1.202-4.337) 0.012 1.831 (0.935-3.584) 0.018
Lymph node status 0.710 (0.411-1.229) 0.221
No. of lymph nodes resected 0.661 (0.411-1.061) 0.087
Histological subtype 0.456 (0.243-0.854) 0.014 0.469 (0.225-0.974) 0.042
Differentiation 0.439 (0.266-0.725) 0.001 0.662 (0.374-1.170) 0.156
CA19-9 2.458 (1.526-3.960) 0.000 3.372 (1.968-5.778) 0.000
CEA 1.268 (0.790-2.036) 0.326 0.608 (0.356-1.038) 0.072
Chemotherapy 2.157 (1.323-3.514) 0.002 3.817 (2.194-6.639) 0.000

CRC: Colorectal cancer; LAP: Laparoscopic surgery; OPEN: Open surgery; p-Pathological; CA19-9: Carbohydrate antigen 19-9; CEA: Carcinoembryonic antigen; HR: Hazard ratio.